The recurrent Guillain-Barré syndrome: A long-term population-based study

Acta Neurologica Scandinavica

Volumn 126, Issue 3, 2012, Pages 154-161

  Mossberg, N ^a   Nordin, M ^a   Movitz, C ^a   Nilsson, S ^b   Hellstrand, K ^a   Bergstrom T ^a   Andersson, B ^a   Andersen, O ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Campylobacter jejuni; Guillain Barr syndrome; Immunology; Neurophysiology; Prognosis; Recurrence; Viral infections

Indexed keywords

ADULT; AGED; ARACHNOIDITIS; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HOSPITAL ADMISSION; HUMAN; IMMUNE DEFICIENCY; MALE; NEUROLOGY; NEUROPHYSIOLOGY; RECURRENT DISEASE; REMISSION; SEROLOGY;

ADULT; AGED; COMMUNITY HEALTH PLANNING; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 84864544971     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2012.01667.x     Document Type: Article

References (34)

1. Ruts L, van Koningsveld R, van Doorn PA . Distinguishing acute-onset CIDP from Guillain-Barre syndrome with treatment related fluctuations. Neurology 2005;65:138-40.
2. Ruts L, Drenthen J, Jacobs BC, van Doorn PA . Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology 2010;74:1680-6.
3. Dionne A, Nicolle MW, Hahn AF . Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy. Muscle Nerve 2010;41:202-7.
4. Kuitwaard K, van Koningsveld R, Ruts L, Jacobs BC, van Doorn PA . Recurrent Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2009;80:56-9.
5. Grand'Maison F, Feasby TE, Hahn AF, Koopman WJ . Recurrent Guillain-Barre syndrome. Clinical and laboratory features. Brain 1992;115 (Pt 4):1093-106.
6. Taly AB, Gupta SK, Anisya V et al. Recurrent Guillain-Barre' syndrome: a clinical, electrophysiological and morphological study. J Assoc Physicians India 1995;43:249-52.
7. Mossberg N, Andersen O, Nilsson S et al. Oxygen radical production and severity of the Guillain-Barre syndrome. J Neuroimmunol 2007;192:186-91.
8. Mossberg N, Andersen O, Nordin M et al. Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barre syndrome. J Inflamm (Lond) 2010;7:40.
9. Asbury AK, Cornblath DR . Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27 Suppl:S21-4.
10. Das A, Kalita J, Misra UK . Recurrent Guillain Barre' syndrome. Electromyogr Clin Neurophysiol 2004;44:95-102.
11. Ahlmen J, Andersen O, Hallgren G, Peilot B . Positive effects of tacrolimus in a case of CIDP. Transplant Proc 1998;30:4194.
12. Kleyweg RP, van der Meche FG, Schmitz PI . Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve 1991;14:1103-9.
13. Falck B . Neurography - motor and sensory nerve conduction studies. In: Daube J, ed. Handbook of clinical neurophysiology. Amsterdam: Elsevier, 2003; 269-321.
14. Stalberg E, Falck B, Sonoo M, Stalberg S, Astrom M . Multi-MUP EMG analysis-a two year experience in daily clinical work. Electroencephalogr Clin Neurophysiol 1995;97:145-54.
15. Van den Bergh PY, Pieret F . Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004;29:565-74.
16. Svedhem A, Gunnarsson H, Kaijser B . Diffusion-in-gel enzyme-linked immunosorbent assay for routine detection of IgG and IgM antibodies to Campylobacter jejuni. J Infect Dis 1983;148:82-92.
17. Gaines H, Biberfeld G . Measurement of lymphoproliferation at the single-cell level by flow cytometry. Methods Mol Biol 2000;134:243-55.
18. Svahn A, Linde A, Thorstensson R, Karlen K, Andersson L, Gaines H . Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. J Immunol Methods 2003;277:17-25.
19. Fredman P, Lekman A . Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders. Neurochem Res 1997;22:1071-83.
20. Svennerholm L. Structure and function of gangliosides. In: Svennerholm L, Mandel P, Dreyfus H, Urban P.-F., eds. New York, NY: Plenum, 1980.
21. Soysal A, Aysal F, Caliskan B et al. Clinico-electrophysiological findings and prognosis of Guillain-Barre syndrome - 10 years' experience. Acta Neurol Scand 2011;123:181-6.
22. Wijdicks EF, Ropper AH . Acute relapsing Guillain-Barre syndrome after long asymptomatic intervals. Arch Neurol 1990;47:82-4.
23. Dyck PJ, Arnason B . Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy, 2nd edn. Philadelphia, PA: W.B. Saunders, 1984; 2101-14.
24. Hughes RA, Bouche P, Cornblath DR et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-32.
25. Zivkovic SA, Peltier AC, Iacob T, Lacomis D . Chronic inflammatory demyelinating polyneuropathy and ventilatory failure: report of seven new cases and review of the literature. Acta Neurol Scand 2011;124:59-63.
26. Fross RD, Daube JR . Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987;37:1493-8.
27. Byun WM, Park WK, Park BH, Ahn SH, Hwang MS, Chang JC . Guillain-Barre syndrome: MR imaging findings of the spine in eight patients. Radiology 1998;208:137-41.
28. Georgy BA, Chong B, Chamberlain M, Hesselink JR, Cheung G . MR of the spine in Guillain-Barre syndrome. AJNR Am J Neuroradiol 1994;15:300-1.
29. Echaniz-Laguna A, Philippi N . Teaching neuroimages: Chronic inflammatory demyelinating polyradiculoneuropathy causing spinal cord compression. Neurology 2009;72:e121.
30. Kuitwaard K, van der Pol WL, Ruts L, van Doorn PA . Individual patients who experienced both Guillain-Barre syndrome and CIDP. J Peripher Nerv Syst 2009;14:66-8.
31. Jacobs BC, Rothbarth PH, van der Meche FG et al. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology. 1998;51:1110-5.
32. Hadden RD, Karch H, Hartung HP et al. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 2001;56:758-65.
33. Tagawa Y, Yuki N, Hirata K . High anti-GM1 and anti-GD1a IgG antibody titers are detected in Guillain-Barre syndrome but not in chronic inflammatory demyelinating polyneuropathy. Eur Neurol 2002;48:118-9.
34. Rosenberg SK, Stacey BR . Postoperative Guillain-Barre syndrome, arachnoiditis, and epidural analgesia. Reg Anesth 1996;21:486-9.